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bstract
ntroduction: Charcot-Marie-Tooth disease (CMT) is one of the
ost commonly inherited neuromuscular diseases – there is no
ffective treatment. Foot and ankle weakness is a major problem
or children with CMT, thus interventions that focus on main-
aining and increasing strength may  provide a solution. Research
uestion: Is progressive resistance strength training an effective
nd safe intervention to improve strength, disability, gait and qual-
ty of life of children with CMT? Participants and Setting: Sixty
hildren (6 to 17 years) with conﬁrmed CMT  who reside in Sydney,
ustralia will be recruited via referral from a paediatric neurolo-
ist, advertisements or the Australasian Paediatric CMT  Registry.
ntervention: Participants will be randomised to undergo a 24-
eek, thrice weekly, high-intensity progressive resistance foot
nd ankle exercise programme (HIGH) or low-intensity foot and
nkle exercise control programme (LOW). Measurements: Out-
ome measures will be conducted at baseline, 6, 12 and 24 months.
he primary outcome is isometric dorsiﬂexion strength measured
y hand-held dynamometry. Secondary outcomes include disabil-
ty, gait, quality of life, functional ankle instability and muscle
olume and fatty inﬁltration of the anterior compartment of the
ower leg (determined by MRI). Procedure: Randomisation and
allocation will be by a computer-generated algorithm, maintained
and assigned by an external phone-based system, concealed to
the investigators. Participants, parents and the outcome assessors
will be blinded to group assignment. Analysis: Treatment effect
between groups is by intention-to-treat with a linear regression
approach to analysis of covariance using 95% CI and p < 0.05.
Discussion: This study is the ﬁrst randomised controlled trial to
evaluate the risks and beneﬁts of strengthening the affected mus-
cles in children with CMT.
Trial registration: Australian New Zealand Clinical Trials Registry.
Registration number: ACTRN12613000552785. Was  this trial
prospectively registered: Yes. Funded by: Muscular Dystrophy
Association USA. Funder approval number: 250931. Anticipated
completion: July 2016. Correspondence: Amy  D Sman, Institute
for Neuroscience and Muscle Research, The Children’s Hospital at
Westmead – The University of Sydney, Westmead, 2145, New South
Wales, Australia. Email: amy.sman@health.nsw.gov.au
Full protocol: Available on the eAddenda at doi:10.1016/j.jphys.
2013.12.015
http://dx.doi.org/10.1016/j.jphys.2013.12.015
ommentary
The most signiﬁcant functional handicap in children with
harcot-Marie-Tooth disease (CMT) results from the progressive
eakness of the foot dorsiﬂexion muscles. The functional loss of
orsiﬂexion means a complete change in mobility and has a high
mpact on quality of life.1 Improving motor function with the aid of
esistance training has been proven for people with no neuromus-
ular problems. The translation from healthy children to diseased
hildren never been researched before for distal muscles. The safety
f resistance training has never previously been evaluated in a con-
rolled study.2
The protocol by Sman et al. can be seen as a major step towards
olving several questions that have arisen from the resistance
raining approach in distal leg muscles for people with CMT. The
wo arms that combine high-intensity exercise training and low-
ntensity exercise training is unique. The value of this study, which
ims to gather all aspects of resistance training with regard to
measure like dorsiﬂexion strength and a secondary outcome
measure of a more speciﬁc composite scale like the CMTPedS is
highly recommended.3 The implementation of muscle MRI  will give
a closer view of disease progression and will be of high interest.
However, generally, the value of this technique is limited beyond
inﬂammation with respect to clinical functionality in neuromuscu-
lar disorders.4 From a CMT-speciﬁc point of view the usefulness of
MRI  is still being debated5 and will possibly be inspired by these
investigated clinical questions.
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